Richard Allan Davies

Senioringeniør

Vis forfatter(e) (2022). Impaired activation of STAT5 upon IL-2 stimulation in Tregs and elevated sIL-2R in Sjögren’s syndrome. Arthritis Research & Therapy. 12 sider.
Vis forfatter(e) (2022). Harmonization and qualification of intracellular cytokine staining to measure influenza-specific CD4<sup>+</sup> T cell immunity within the FLUCOP consortium. Frontiers in Immunology. 14 sider.
Vis forfatter(e) (2022). Harmonization and qualification of an IFN-γ Enzyme-Linked ImmunoSpot assay (ELISPOT) to measure influenza-specific cell-mediated immunity within the FLUCOP consortium. Frontiers in Immunology. 14 sider.
Vis forfatter(e) (2022). Aberrant signaling of immune cells in Sjögren's syndrome patient subgroups upon interferon stimulation. Frontiers in Immunology. 13 sider.

Vis forfatter(e) (2021). Humoral and cellular immune responses in critically ill influenza A/H1N1-infected patients. Scandinavian Journal of Immunology. 1-9.

Vis forfatter(e) (2019). Single cell based phosphorylation profiling identifies alterations in toll-like receptor 7 and 9 signaling in patients with primary sjogren's syndrome. Frontiers in Immunology. 1-18.

Vis forfatter(e) (2018). Phosphorylation of intracellular signaling molecules in peripheral blood cells from psoriasis patients on originator or biosimilar infliximab. British Journal of Dermatology. 371-380.
Vis forfatter(e) (2018). Improving influenza vaccines: challenges to effective implementation. Current Opinion in Immunology. 88-95.